SERPING1 and hereditary angioedema: If challenges relating to the rare nature of pediatric HAE can be addressed, future studies could assess larger samples over longer periods of time to provide more robust information on the long-term preventative efficacy, safety and tolerability of lanadelumab and C1-INH.